Hormone Positive HER2 Negative Breast Cancer Metastatic to the Rectum: A Case Report

Aref Chehal

Oncology and Hematology Department, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.

Ashraf Alakkad *

Internal Medicine Department, Madinat Zayed Hospital, AL Dhafra Region, UAE.

Ashok Uttamchandani

Oncology and Hematology Department, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.

Rawia Mohamed

Pathology Department, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.

Robert Douglas Church

General Surgery Department, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.

Sonia Otsmane

Oncology and Hematology Department, Cleveland Clinic, Abu Dhabi, UAE.

*Author to whom correspondence should be addressed.


Abstract

Background: The rectum is an uncommon site for metastases from Invasive Ductal Carcinoma (IDC) of the breast, and it poses risks such as perforation and obstruction.

Case Report: A 50-year-old non-diabetic, non-alcoholic, and nonsmoker premenopausal female patient diagnosed with rectal metastasis primarily originating from breast cancer.

In 2009, the patient was diagnosed with stage IV hormone positive, Her-2 (+2) negative, FISH positive right breast cancer with cervical (C6) vertebrae metastasis seen on PET scan. As she had oligo metastasis with a single bony focus, she was treated with intent to cure. For this purpose, she received radiation therapy to the cervical vertebrae, resulting in a complete response. This was followed by pseudo-neoadjuvant chemotherapy with six cycles of Docetaxel and trastuzumab. The patient then underwent a right-modified radical mastectomy. The pathology showed no complete response with residual 2.5 cm invasive carcinoma (PT2), and 4 out of 25 Axillary lymph nodes were positive for metastases (PN2). She was given (pseudo) adjuvant radiotherapy to the chest wall and lymphatics and was started on (pseudo) adjuvant tamoxifen. Trastuzumab was completed for one year as a (pseudo) adjuvant setting.

Her disease seemed to be cleared up as no new cancer signs were reported by follow-up full body scans (CT/PET). After seven years, in May 2016, her PET-CT scan showed multiple new hypermetabolic osseous lesions, in keeping with metastasis involving the right shoulder, mid-thoracic spine, left aspect of L5, right sacrum, and the greater trochanteric region of the left femur and left ischium. She also presented a new hypermetabolic retroperitoneal paracaval lymph node, in keeping with metastasis. The new ill-defined hypodensity in the left hepatic lobe was associated with increased FDG uptake, which is suspicious for early metastasis. She also presented a tiny right lung peri-fissural nodularity that was too small to be characterized by PET.

She was treated with Zoladex 3.6 mg injection monthly, Femara 2.5 mg daily, Palbociclib 125 mg PO daily for 21 days over a 28-day cycle, and Denosumab 120 mg monthly. The treatment was initiated in Singapore. As previously stated, Her-2 testing was reported as negative. The patient went into complete remission for more than six years, as documented by the PET scan conducted on January 19, 2022. Later, in June 2022, the patient developed signs and symptoms of intestinal obstruction (abdominal pain, nausea, and vomiting) and was diagnosed with rectal cancer metastases of breast origin.

Conclusion:  As the patient first developed breast cancer with oligo-bony metastasis, which was successfully treated with chemotherapy and radiotherapy, but later relapsed in the lung, liver, lymph nodes, and multiple bony sites. She was treated successfully via hormonal and targeted therapy. Finally, she relapsed in the form of rectal metastasis.

Keywords: Breast cancer, rectal carcinoma, lung metastases, liver metastasis, bone metastasis rectal metastases


How to Cite

Chehal, Aref, Ashraf Alakkad, Ashok Uttamchandani, Rawia Mohamed, Robert Douglas Church, and Sonia Otsmane. 2022. “Hormone Positive HER2 Negative Breast Cancer Metastatic to the Rectum: A Case Report”. Journal of Cancer and Tumor International 12 (4):65-72. https://doi.org/10.9734/jcti/2022/v12i4221.

Downloads

Download data is not yet available.

References

Lau LC, Wee B, Wang S, & Thian YL. Metastatic breast cancer to the rectum: A case report with emphasis on MRI features. Medicine (Baltimore). 2017; 96(17):e6739.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, & Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108.

Ruymbeke H, Harlet L, Stragier B, Steenkiste E, Ryckx M, & Marolleau F. Anorectal metastasis from breast carcinoma: a case report and review of the literature. BMC Research Notes. 2018; 11(1):268.

Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, & Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA: A Cancer Journal for Clinicians. 2016;66(4):271-89.

Ambroggi M, Stroppa EM, Mordenti P, Biasini C, Zangrandi A, & Michieletti E, et al. Metastatic Breast Cancer to the Gastrointestinal Tract: Report of Five Cases and Review of the Literature. International Journal of Breast Cancer. 2012;2012:439023.

Algethami NE, Althagafi AA, Aloufi RA, Al Thobaiti FA, & Abdelaziz HA. Invasive Lobular Carcinoma of the Breast With Rectal Metastasis: A Rare Case Report. Cureus. 2022;14(3).

Abbas TO, Al-Naimi AR, Yakoob RA, Al-Bozom IA, & Alobaidly AM. Prostate cancer metastases to the rectum: A case report. World Journal of Surgical Oncology. 2011;9(1):56.

Hoang DA, Nguyen AQ, Nguyen KT, & Pham MD. Rectal metastasis originating from breast cancer: A rare case report. Annals of Medicine and Surgery. 2022;78:103841.

INOUE H, ARITA T, KURIU Y, SHIMIZU H, KIUCHI J, & YAMAMOTO Y, et al. Colonic Metastasis from Breast Cancer: A Case Report and Review of the Literature. In Vivo. 2022;36(1):522-7.

Lau LC, Wee B, Wang S, & Thian YL. Metastatic breast cancer to the rectum: A case report with emphasis on MRI features. Medicine. 2017;96(17):e6739.

Ambroggi M, Stroppa EM, Mordenti P, Biasini C, Zangrandi A, & Michieletti E, et al. Metastatic breast cancer to the gastrointestinal tract: report of five cases and review of the literature. International Journal of Breast Cancer. 2012;2012.

Galanopoulos M, Gkeros F, Liatsos C, Pontas C, Papaefthymiou A, & Viazis N, et al. Secondary metastatic lesions to colon and rectum. Annals of gastroenterology. 2018;31(3):282.

Lau LC, Wee B, Wang S, & Thian YL. Metastatic breast cancer to the rectum: a case report with emphasis on MRI features. Medicine. 2017;96(17).

Charan M, Verma AK, Hussain S, Misri S, Mishra S, Majumder S, Ramaswamy B, Ahirwar D, Ganju RK. Molecular and cellular factors associated with racial disparity in breast cancer. International Journal of Molecular Sciences. 2020; 21(16):5936.

Available:https://doi.org/10.3390/ijms21165936

Benfiguig A, Anciaux M, Eugène C, Benkemoun G, & Etienne J. Gastric metastasis of breast cancer occurring after a cancer-free interval of 30 years. Annales de Gastroenterologie et d'Hepatologie; 1992.